Treatment with bortezomib of human CD4(+) T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Por Blanco, Belén, Pérez-Simón, José A., Sánchez-Abarca, Luis I., Caballero-Velazquez, Teresa, Gutierrez-Cossío, Silvia, Hernández-Campo, Pilar, Díez-Campelo, María, Herrero-Sanchez, Carmen, Rodriguez-Serrano, Concepción, Santamaría, Carlos, Sánchez-Guijo, Fermín M., del Cañizo, Consuelo, San Miguel, Jesús F.
Publicado em 2009

Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects

Por Garcia-Gomez, Antonio, Ocio, Enrique M., Crusoe, Edvan, Santamaria, Carlos, Hernández-Campo, Pilar, Blanco, Juan F., Sanchez-Guijo, Fermin M., Hernández-Iglesias, Teresa, Briñón, Jesús G., Fisac-Herrero, Rosa M., Lee, Francis Y., Pandiella, Atanasio, San Miguel, Jesús F., Garayoa, Mercedes
Publicado em 2012